The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Daiichi Sankyo; GlycoMimetics; Merck
Other Relationship - Celgene; GlycoMimetics
S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Cardinal Health; Castle Biosciences
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria
Other Relationship - Immunocore; Reata Pharmaceuticals
 
Megan Othus
No Relationships to Disclose
 
James Moon
No Relationships to Disclose
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics; NanoString Technologies; Novartis
 
Elizabeth Iannotti Buchbinder
Employment - Alexion Pharmaceuticals (I); Biodesix (I); Sanofi (I)
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Lilly; Merck; Novartis
 
Vernon K. Sondak
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck/Schering Plough; Novartis; Pfizer; Polynoma; Regeneron; Replimune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Polynoma; Replimune
 
Michael C. Lowe
Research Funding - Delcath Systems (Inst); Vaccinex (Inst)
 
Danae Campos
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Larissa A. Korde
No Relationships to Disclose
 
William Edgar Carson
Consulting or Advisory Role - Dragonfly Therapeutics
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; ImaginAb; Lutris; Merus; PACT Pharma; Rgenix; Tango Therapeutics
Honoraria - Amgen; Chugai/Roche; Genentech/Roche; Merck Sharp & Dohme; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Chugai Pharma; Merck; Novartis; Sanofi
Research Funding - Agilent (Inst); Bristol-Myers Squibb (Inst)
 
Kenneth F. Grossmann
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Castle Biosciences; Novartis; Roche/Genentech